Side-by-side comparison of AI visibility scores, market position, and capabilities
AI character platform with hundreds of millions of users; create and chat with personas, founded by Transformer co-inventor Noam Shazeer at $5B valuation.
Character.AI is an AI platform enabling users to create and chat with AI personas — fictional characters, historical figures, celebrity-style bots, and original creations — through a conversational interface that maintains consistent character personalities across extended dialogues. Founded in 2021 by Noam Shazeer (co-inventor of the Transformer architecture) and Daniel De Freitas, both former Google engineers, Character.AI quickly amassed one of the largest and most engaged user bases of any consumer AI product.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.